米国のフェリチン検査市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、手法別、検査タイプ別、最終用途別、セグメント別予測、2025年～2033年

米国のフェリチン検査市場規模および動向：

米国のフェリチン検査市場規模は2024年に2億7,460万米ドルと推計され、2025年から2033年にかけてCAGR 5.63％で成長すると予測されています。

市場を牽引しているのは、鉄欠乏性貧血の有病率の上昇と、炎症性疾患、慢性腎臓病、がんなどの関連慢性疾患です。

鉄貯蔵と炎症のバイオマーカーとしてのフェリチンの重要性に対するヘルスケア専門家の意識の高まりは、日常的な健康スクリーニングと特殊な診断プロトコルの両方におけるフェリチンの採用拡大につながりました。加えて、貧血や栄養不足に陥りやすい老年人口の拡大が、臨床現場におけるフェリチン検査の需要を高めています。

何百万人もの出産適齢期の女性や5歳未満の幼児が貧血に苦しんでいる可能性が高く、疲労、脱力感、息切れなどの症状を経験しています。このような衰弱は、彼女たちの健康と生産性を低下させるだけでなく、家族、地域社会、そして国家の開発にも広く影響を及ぼします。下のグラフは、2021年から2023年までの米国における貧血の発生率を示しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国のフェリチン検査市場の変数、動向、範囲

• 市場イントロダクション/系統展望
• 市場規模と成長見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 米国のフェリチン検査市場分析ツール
  • ポーター分析
  • PESTEL分析

第4章 米国のフェリチン検査市場：製品推定・動向分析

• 米国のフェリチン検査市場：製品変動分析
• 製品別、2024年および2033年
• キット
• 試薬
• 機器

第5章 米国のフェリチン検査市場：用途推定・動向分析

• 米国のフェリチン検査市場：用途変動分析
• 用途別、2024年および2033年
• 貧血
• ヘモクロマトーシス
• 鉛中毒
• 妊娠
• その他

第6章 米国のフェリチン検査市場：最終用途推定・動向分析

• 米国のフェリチン検査市場：最終用途変動分析
• 最終用途別、2024年および2033年
• 病院

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 企業ヒートマップ分析
• 企業プロファイル
• 企業プロファイル/上場企業
  • Eurolyser Diagnostica GmbH
  • Cortez Diagnostics Inc
  • Pointe Scientific, Inc
  • Aviva Systems Biology Corporation
  • bioMerieux SA
  • Abnova Corporation
  • CTK Biotech, Inc
  • Thermo Fisher Scientific Inc.

List of Tables

• Table 1 List of abbreviation
• Table 2 US ferritin testing market, by region, 2021 - 2033 (USD Million)
• Table 3 US ferritin testing market, by product, 2021 - 2033 (USD Million)
• Table 4 US ferritin testing market, by application, 2021 - 2033 (USD Million)
• Table 5 US ferritin testing market, by end-use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 US ferritin testing market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segment snapshot-1
• Fig. 14 Segment snapshot-2
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Market trends & outlook
• Fig. 17 Porter's five force analysis
• Fig. 18 PESTEL analysis
• Fig. 19 US ferritin testing market: Product movement analysis
• Fig. 20 US ferritin testing market, for Instrument, 2021 - 2033 (USD Million)
• Fig. 21 US ferritin testing market, for Reagent, 2021 - 2033 (USD Million)
• Fig. 22 US ferritin testing market, for Kits, 2021 - 2033 (USD Million)
• Fig. 23 US ferritin testing market, Application Movement Analysis
• Fig. 24 US ferritin testing market, for Anemia, 2021 - 2033 (USD Million)
• Fig. 25 US ferritin testing market, for Hemochromatosis, 2021 - 2033 (USD Million)
• Fig. 26 US ferritin testing market, for Lead Poisoning, 2021 - 2033 (USD Million)
• Fig. 27 US ferritin testing market, for Pregnancy, 2021 - 2033 (USD Million)
• Fig. 28 US ferritin testing market, for Others, 2021 - 2033 (USD Million)
• Fig. 29 US ferritin testing market, End-use Movement Analysis
• Fig. 30 US ferritin testing market, for Hospitals, 2021 - 2033 (USD Million)
• Fig. 31 US ferritin testing market, for Diagnostic Laboratories, 2021 - 2033 (USD Million)

U.S. Ferritin Testing Market Size & Trends:

The U.S. ferritin testing market size was estimated at USD 274.60 million in 2024 and is projected to grow at a CAGR of 5.63% from 2025 to 2033. The market is driven by the rising prevalence of iron deficiency anemia and related chronic conditions such as inflammatory diseases, chronic kidney disease, and cancer.

Increasing awareness among healthcare professionals about the importance of ferritin as a biomarker for iron storage and inflammation has led to its growing adoption in both routine health screenings and specialized diagnostic protocols. In addition, the expanding geriatric population is more susceptible to anemia and nutritional deficiencies has amplified the demand for ferritin testing in clinical settings.

Millions of women of childbearing age and young children under five are likely suffering from anemia, experiencing symptoms like fatigue, weakness, and shortness of breath. These debilitating effects not only diminish their health and productivity but also have a broader impact on families, communities, and the development of nations. The chart below illustrates the incidence of anemia in the U.S. from 2021 to 2023.

U.S. Ferritin Testing Market Report Segmentation

This report forecasts revenue growth at, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. ferritin testing market report based on product, application, technique, test type, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instrument
• Reagent
• Kits
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Anemia
• Hemochromatosis
• Lead Poisoning
• Pregnancy
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostic Laboratories

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Ferritin Testing Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
    • 3.3.1.1. Rising Prevalence of Iron-Deficiency Anemia
    • 3.3.1.2. Increased Adoption of Preventive Health Screenings
    • 3.3.1.3. Advancements in Point-of-Care and At-Home Testing Kits
  • 3.3.2. Market Restraints Analysis
    • 3.3.2.1. Stringent Regulations
  • 3.3.3. Market Opportunities Analysis
  • 3.3.4. Market Challenges Analysis
    • 3.3.4.1. Product Recalls
• 3.4. U.S. Ferritin Testing Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. U.S. Ferritin Testing Market: Product Estimates & Trend Analysis

• 4.1. U.S. Ferritin Testing Market: Product Movement Analysis
• 4.2. U.S. Ferritin Testing Market Estimates and Forecasts, by Product (USD Million), 2024 & 2033
• 4.3. Kits
  • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Reagents
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Instrument
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Ferritin Testing Market: Application Estimates & Trend Analysis

• 5.1. U.S. Ferritin Testing Market: Application Movement Analysis
• 5.2. U.S. Ferritin Testing Market Estimates and Forecasts, by Application (USD Million), 2024 & 2033
• 5.3. Anemia
  • 5.3.1. Anemia Market, 2021 - 2033 (USD Million)
• 5.4. Hemochromatosis
  • 5.4.1. Hemochromatosis Market, 2021 - 2033 (USD Million)
• 5.5. Lead Poisoning
  • 5.5.1. Lead Poisoning Market, 2021 - 2033 (USD Million)
• 5.6. Pregnancy
  • 5.6.1. Pregnancy Market, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Ferritin Testing Market: End Use Estimates & Trend Analysis

• 6.1. U.S. Ferritin Testing Market: End-use Movement Analysis
• 6.2. U.S. Ferritin Testing Market Estimates and Forecasts, by End-use (USD Million), 2024 & 2033
• 6.3. Hospitals
  • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
• 7.5. Company Profiles/Listing
  • 7.5.1. Eurolyser Diagnostica GmbH
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Collection Site Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Cortez Diagnostics Inc
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Collection Site Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Pointe Scientific, Inc
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Collection Site Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Aviva Systems Biology Corporation
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Collection Site Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. bioMerieux S.A
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Collection Site Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Abnova Corporation
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Collection Site Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. CTK Biotech, Inc
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Collection Site Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Thermo Fisher Scientific Inc.
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Collection Site Benchmarking
    • 7.5.8.4. Strategic Initiatives